Clinical effect of white matter network disruption related to amyloid and small vessel disease - Test2 - elhamkhani - TriplyDB

Clinical effect of white matter network disruption related to amyloid and small vessel disease

Clinical effect of white matter network disruption related to amyloid and small vessel disease

http://www.wikidata.org/entity/Q35850730

about

Measuring Cortical Connectivity in Alzheimer's Disease as a Brain Neural Network Pathology: Toward Clinical Applications.Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia.Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report Scale-integrated Network Hubs of the White Matter Structural Network Advanced Neuroimaging of Cerebral Small Vessel Disease.Coronary artery calcium is associated with cortical thinning in cognitively normal individuals.18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.Association of Cerebral Small Vessel Disease Burden and Health-Related Quality of Life after Acute Ischemic Stroke.Longitudinal cortical thinning and cognitive decline in patients with early- versus late-stage subcortical vascular mild cognitive impairment.Global Performance of Executive Function Is Predictor of Risk of Frailty and Disability in Older Adults.Mental speed is associated with the shape irregularity of white matter MRI hyperintensity load.PET imaging of the neurovascular interface in cerebrovascular disease.The effect of the total small vessel disease burden on the structural brain network.Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease

P2860

Q31047403-3C57E354-4E07-4DCF-93E4-38016D128F71 Q31076171-D1DDE1A1-4187-4DAA-B108-D080ADF6BFF2 Q33721681-470B0AF5-A571-42CB-8D95-A373E4E9B71E Q33732768-4B3F58AD-F603-4D07-BB1D-A40A6A78E0AE Q33840907-98CBA380-14A3-41BD-BC9E-07E7156A4F24 Q37303653-800D7866-A396-4DA9-8D1A-D51898021A0E Q38404963-1A369A22-BFD6-41DB-B35C-1CE1E70ADAA9 Q45996545-CBF4378F-4A5D-43CD-85C2-C4AEE67E07B6 Q46126036-0CB2228C-C1F4-4642-989E-F5688DE8A001 Q47399847-5421CDE7-AE5F-4B9A-B66B-088096C0822F Q47691996-A1DBF8B9-807B-4035-8088-12DFA1586DBC Q47894598-6DF5579C-EE65-4BD8-B0EB-B1B75635CE42 Q48031424-CDB875DE-A9F0-4E51-BB30-87C7C644E901 Q55083526-629469BE-3943-406C-8F32-6ECA298AE463 Q58766976-ED2F4942-9294-49EA-9343-3B2D06B410DB

P2860

Clinical effect of white matter network disruption related to amyloid and small vessel disease

http://www.wikidata.org/entity/Q35850730

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical effect of white matte ...... yloid and small vessel disease

@ast

Clinical effect of white matte ...... yloid and small vessel disease

@en

type

label

Clinical effect of white matte ...... yloid and small vessel disease

@ast

Clinical effect of white matte ...... yloid and small vessel disease

@en

prefLabel

Clinical effect of white matte ...... yloid and small vessel disease

@ast

Clinical effect of white matte ...... yloid and small vessel disease

@en

P1433

Q35850730-AFCE4E82-D8C9-4A45-AA0F-56EFC303F8EE

P1476

Q35850730-4B1B3E90-FCEF-40BE-8D90-9125C5C9D08E

P2093

Q35850730-00C271EA-8448-4E09-9570-FE36D33354C2

Q35850730-16670763-BB35-4656-8AC7-E5A4F284A5FC

Q35850730-29978DFC-BCC8-4721-971F-9D509CA31D89

Q35850730-2AEC922C-7A44-4D8B-936F-7855CACCF41F

Q35850730-34650F35-0471-4726-A858-480F8E5DB45F

Q35850730-3669E61E-C00A-4867-8611-1232422E45FF

Q35850730-3B50F615-3FD2-45F4-9503-CEFDBC380162

Q35850730-531D50E7-2623-40D9-9BF4-BC39D43896B6

Q35850730-61BD3F5A-FCB1-478F-A82D-7D42B1D7162E

Q35850730-63E3F26F-68B0-4A82-9C88-485F33B14AA5

P2860

Q35850730-02EAA3E8-C2A6-463B-A0D4-82C78A558385

Q35850730-05DBFD4C-D76A-4D0B-ACD4-D9A2FEE01688

Q35850730-06EE1FB3-5D52-4D1E-AC64-1BA797903ADE

Q35850730-0A1664B7-B827-4579-A090-6C035F6ED7E6

Q35850730-0DB00C25-30C6-4839-8653-3A8B2759BF62

Q35850730-28170629-3C58-4871-B58E-128CE068FBDF

Q35850730-2B7611DE-7F44-47BC-B0A0-5BABB19B1EDB

Q35850730-3D765701-9FA2-4885-B550-4A46810435B1

Q35850730-46F61E7F-51BD-4CCC-A7AC-0E57430133C0

Q35850730-6877F434-1A91-43DB-8B71-F0011C508B12

P304

Q35850730-B450FB15-07D1-4C1A-9C3E-2C6E837F743F

P31

Q35850730-B44872D3-EF56-4815-A6F7-5D96BF8A4019

P356

Q35850730-26277FB3-E58F-4E3C-A7A3-5F3D16C0E2C1

P407

Q35850730-4BD5723C-A8FF-4DC6-864C-86B8CAB24E27

P433

Q35850730-28D32F43-B8DF-4BC2-B72F-F0A18B8D1F80

P478

Q35850730-DFD695D4-766B-4AA3-AECA-27F24DD23273

P50

Q35850730-17197C23-FC8C-45A4-BB55-BB3CB3F997A8

Q35850730-73D42D9E-F604-466B-9A21-04A48F071994

P577

Q35850730-E58ED206-A32B-4C10-9D6D-BE7CF0C7ABB0

P698

Q35850730-6D394FEE-DC55-46D4-8F15-9B749D2C9B74

P932

Q35850730-3D495254-8788-4654-A0D6-CDF50DF9B0BB

P356

WNL.0000000000001705

P1433

P1476

Clinical effect of white matte ...... yloid and small vessel disease

@en

P2093

Changsoo Kim

http://www.w3.org/2001/XMLSchema#string

Duk L Na

http://www.w3.org/2001/XMLSchema#string

En-Da Ko

http://www.w3.org/2001/XMLSchema#string

Geon Ha Kim

http://www.w3.org/2001/XMLSchema#string

Hee Jin Kim

http://www.w3.org/2001/XMLSchema#string

Hunki Kwon

http://www.w3.org/2001/XMLSchema#string

Jae Hong Lee

http://www.w3.org/2001/XMLSchema#string

Jae Seung Kim

http://www.w3.org/2001/XMLSchema#string

Jong-Min Lee

http://www.w3.org/2001/XMLSchema#string

Kiho Im

http://www.w3.org/2001/XMLSchema#string

P2860

The human connectome: A structural description of the human brain

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Diffusion spectrum magnetic resonance imaging (DSI) tractography of crossing fibers

Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging

Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI

A Network Diffusion Model of Disease Progression in Dementia

Complex network measures of brain connectivity: uses and interpretations

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

P304

63-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000001705

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26062629

http://www.w3.org/2001/XMLSchema#string

P932

4501945

http://www.w3.org/2001/XMLSchema#string